The accuracy of an at-home cancer test designed to assess an individual’s risk of developing certain cancers is under scrutiny following concerns from several physicians.
Despite initial marked success rates of over 87 percent sensitivity and about 90 percent specificity rate touted in a 2021 study, physicians have reported instances of false positives and false negatives.
